NCT07786623

Brief Summary

This study is a single-center, observational study designed to collect tissue spectrometric data related to tissue oxygenation.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
57mo left

Started Dec 2026

Longer than P75 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 20, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 26, 2026

Completed
3 months until next milestone

Study Start

First participant enrolled

December 1, 2026

Expected
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

3.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2031

Last Updated

August 26, 2026

Status Verified

August 1, 2026

Enrollment Period

1.1 years

First QC Date

August 20, 2026

Last Update Submit

August 25, 2026

Conditions

Keywords

tissue oxygenationcytochrome c oxidasenear-infrared spectroscopyintraoperative monitoringmedical device

Outcome Measures

Primary Outcomes (1)

  • Observe changes in skeletal muscle tissue oxygenation

    To observe the changes in skeletal muscle tissue oxygenation (combined hemoglobin/myoglobin saturation, %) measured by the SpectroCor Monitoring System during arterial clamping and restoration of limb perfusion. Continuous spectroscopic measurement of combined hemoglobin and myoglobin oxygen saturation in skeletal muscle of the operated limb, recorded from a SpectroCor Sensor placed in the distal wound before any arterial clamping. Saturation values are time-stamped against intraoperative events affecting limb perfusion (proximal arterial clamping, unclamping, graft revision) and compared with paired arterial and venous blood gas samples obtained before clamping and after restoration of blood flow.

    From sensor placement prior to arterial clamping until restoration of limb blood circulation and completion of vascular reconstruction quality control (intraoperative period, approximately 2-6 hours)

Secondary Outcomes (1)

  • Incidence of adverse events, adverse device effects, and device deficiencies

    From sensor placement during the operation until discharge from hospital (up to 30 days)

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

A Helsinki University Hospital patient scheduled for a vascular surgical operation.

You may qualify if:

  • Adults, age of 18 - 90 years
  • Scheduled for peripheral arterial bypass surgery.
  • Scheduled for proximal arterial reconstruction.
  • Ability and willingness to provide informed consent.

You may not qualify if:

  • Inability to provide informed consent
  • Considered a vulnerable person according to the Finnish Medical Research Act (488/1999), Chapter 2, Sections 7, 9, and 10, including retarded persons, pregnant women, nursing mothers, prisoners, and forensic patients.
  • A known history of severe allergic reaction to nickel.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (9)

  • Keller A. Noninvasive tissue oximetry for flap monitoring: an initial study. J Reconstr Microsurg. 2007 May;23(4):189-97. doi: 10.1055/s-2007-974655.

    PMID: 17530610BACKGROUND
  • Keller A. A new diagnostic algorithm for early prediction of vascular compromise in 208 microsurgical flaps using tissue oxygen saturation measurements. Ann Plast Surg. 2009 May;62(5):538-43. doi: 10.1097/SAP.0b013e3181a47ce8.

    PMID: 19387157BACKGROUND
  • Steele MH. Three-year experience using near infrared spectroscopy tissue oximetry monitoring of free tissue transfers. Ann Plast Surg. 2011 May;66(5):540-5. doi: 10.1097/SAP.0b013e31820909f9.

    PMID: 21301288BACKGROUND
  • Chen Y, Shen Z, Shao Z, Yu P, Wu J. Free Flap Monitoring Using Near-Infrared Spectroscopy: A Systemic Review. Ann Plast Surg. 2016 May;76(5):590-7. doi: 10.1097/SAP.0000000000000430.

    PMID: 25664408BACKGROUND
  • Tran PC, DeBrock W, Lester ME, Hartman BC, Socas J, Hassanein AH. The False Positive Rate of Transcutaneous Tissue Oximetry Alarms in Microvascular Breast Reconstruction Rises after 24 Hours. J Reconstr Microsurg. 2021 Jun;37(5):453-557. doi: 10.1055/s-0040-1719048. Epub 2020 Oct 31.

    PMID: 33129214BACKGROUND
  • Ali J, Cody J, Maldonado Y, Ramakrishna H. Near-Infrared Spectroscopy (NIRS) for Cerebral and Tissue Oximetry: Analysis of Evolving Applications. J Cardiothorac Vasc Anesth. 2022 Aug;36(8 Pt A):2758-2766. doi: 10.1053/j.jvca.2021.07.015. Epub 2021 Jul 10.

    PMID: 34362641BACKGROUND
  • Schanzer A, Hevelone N, Owens CD, Belkin M, Bandyk DF, Clowes AW, Moneta GL, Conte MS. Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial. J Vasc Surg. 2007 Dec;46(6):1180-90; discussion 1190. doi: 10.1016/j.jvs.2007.08.033.

    PMID: 18154993BACKGROUND
  • Eiberg JP, Schroeder TV, Vogt KC, Secher NH. Near-infrared spectroscopy during peripheral vascular surgery. Cardiovasc Surg. 1997 Jun;5(3):304-8. doi: 10.1177/096721099700500309.

    PMID: 9293366BACKGROUND
  • Dubosq M, Goueffic Y, Duhamel A, Denies F, Dervaux B, Goyault G, Sobocinski J. Optical Coherence Tomography Contribution Assessment in the Revascularization of Long Femoropopliteal Occlusive Lesions (TASC C and D): A Randomized Trial. Ann Vasc Surg. 2021 Jan;70:362-369. doi: 10.1016/j.avsg.2020.06.061. Epub 2020 Jul 4.

    PMID: 32634565BACKGROUND

MeSH Terms

Conditions

Peripheral Arterial DiseaseChronic Limb-Threatening Ischemia

Condition Hierarchy (Ancestors)

AtherosclerosisArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesPeripheral Vascular DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsIschemia

Study Officials

  • Maarit Venermo, Professor

    Helsinki University Hospital (HUS)

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Tommi Pätilä, PhD

CONTACT

Kalle Kotilahti

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 20, 2026

First Posted

August 26, 2026

Study Start (Estimated)

December 1, 2026

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

July 31, 2031

Last Updated

August 26, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared. Participant consent and the approved Clinical Investigation Plan do not cover secondary sharing of individual-level data, and the sponsor's obligations under Regulation (EU) 2016/679 (GDPR) preclude onward transfer without a valid legal basis. Aggregate results will be published in accordance with the publication policy and made publicly available in EUDAMED, and the clinical investigation report will be submitted to the competent authority within one year of the end of the investigation.